Intratumoral administration of IL2-and TNF-based fusion proteins cures cancer without establishing protective immunity

Download
Full text (accepted version) (PDF, 20.19Mb)
Thumbnail
Open access
Author
Ziffels, Barbara
Pretto, Francesca
Neri, Dariocc
Date
2018-03
Type
    Journal Article
Rights / license
In Copyright - Non-Commercial Use Permitted
Permanent link
https://doi.org/10.3929/ethz-b-000245159
Publication status
published
External links
Journal / series
IMMUNOTHERAPY
Volume
10(3)
Pages / Article No.
177 - 188
Publisher
Future Medicine
Subject
EDA domain of fibronectin; IL2; immunocytokines; intratumoral injection; TNF
Organisational unit
03463 - Neri, Dario (ehemalig) / Neri, Dario (former)  
Funding
670603 - Fulfilling Paul Ehrlich’s Dream: therapeutics with activation on demand (EC)
163479 - Understanding and Exploiting the Molecular Targeting of Tumor Neo-vasculature (SNF)
Notes
project KTI 12803.1
More
Show all metadata
Citations
Cited 11 times in Web of Science
Cited 12 times in Scopus
ETH Bibliography
yes
Altmetrics